It is characterized by a combination of a decreased response to insulin action in target tissues (e.g., muscle or adipose tissue) and impaired insulin secretion from pancreatic β-cells in response to secretory stimuli [9], the latter being the ultimate cause that leads to the development and progression of T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.